Q
Qing Ru Wang
Researcher at Sichuan University
Publications - 3
Citations - 446
Qing Ru Wang is an academic researcher from Sichuan University. The author has contributed to research in topics: Antigen & Immune tolerance. The author has an hindex of 3, co-authored 3 publications receiving 440 citations.
Papers
More filters
Journal ArticleDOI
Immunotherapy of tumors with xenogeneic endothelial cells as a vaccine
Yu Quan Wei,Qing Ru Wang,Xia Zhao,Li Yang,Ling Tian,You Lu,Bin Kang,Chong Jiu Lu,Mei Juan Huang,Yan Yan Lou,Fei Xiao,Qiu Ming He,Jing Mei Shu,Xing Jiang Xie,Yun Qiu Mao,Shong Lei,Feng Luo,Li Qun Zhou,Chong En Liu,Hao Zhou,Yu Jiang,Feng Peng,Liang Ping Yuan,Qiu Li,Yang Wu,Ji Yan Liu +25 more
TL;DR: It is shown that immunotherapy of tumors using fixed xenogeneic whole endothelial cells as a vaccine was effective in affording protection from tumor growth, inducing regression of established tumors and prolonging survival of tumor-bearing mice.
Journal ArticleDOI
Immunogene therapy of tumors with vaccine based on xenopus homologous vascular endothelial growth factor as a model antigen
Yu Quan Wei,Mei Juan Huang,Li Yang,Xia Zhao,Ling Tian,You Lu,Jing Mei Shu,Chong Jiu Lu,Ting Niu,Bin Kang,Yun Qiu Mao,Fen Liu,Yan Jun Wen,Shong Lei,Feng Luo,Li Qun Zhou,Feng Peng,Yu Jiang,Ji Yan Liu,Hao Zhou,Qing Ru Wang,Qiu Ming He,Fei Xiao,Yan Yan Lou,Xing Jiang Xie,Qiu Li,Yang Wu,Zhen Yu Ding,Bin Hu,Min Hu,Wei Zhang +30 more
TL;DR: It is found that immunogene tumor therapy with a vaccine based on XVEGF was effective at both protective and therapeutic antitumor immunity in several tumor models in mice, and may provide a vaccine strategy for cancer therapy through the induction of autoimmunity against the growth factors associated with tumor growth.
Journal ArticleDOI
Induction of apoptosis by norcantharidin in human colorectal carcinoma cell lines: involvement of the CD95 receptor/ligand.
Feng Peng,Yu Quan Wei,Li Tian,Ling-lin Yang,Xia Zhao,You Lu,Yun Qiu Mao,Bing Kan,Song Lei,G.-S. Wang,Yu Jiang,Qing Ru Wang,Feng Luo,Li-qun Zou,Junyong Liu +14 more
TL;DR: The results suggest that norcantharidin triggers apoptosis in colorectal cancer cell lines via the activation of the CD95 receptor/ligand system, and that this agent may be useful for developing new therapeutic regimens for the treatment of coloreCTal carcinoma.